Clinical Utility of Urinary N-Acetyl-ß-D-Glucosaminidase (NAG), Kidney Injury Molecule-1 (KIM-1), and Diffusion-Weighted Renal MRI for the Early Detection of Sickle Cell Nephropathy in Children

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
To evaluate the diagnostic performance of urinary N-acetyl-β-D-glucosaminidase (NAG) and kidney injury molecule-1 (KIM-1) Biomarkers for detection of early onset of Sickle Cell Nephropathy in children under HU therapy
Epistemonikos ID: c130c9b128136306eb13f575ed22c79aa5fdc827
First added on: Aug 26, 2026